Related Experiment Video
Updated: Jun 26, 2025

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial
Epco Hasker1, Younoussa Assoumani2, Andriamira Randrianantoandro3
1Institute of Tropical Medicine, Antwerp, Belgium.
Single-dose rifampicin post-exposure prophylaxis (SDDR-PEP) shows promise in reducing leprosy incidence, particularly when administered broadly. Targeted screening around infected individuals enhances its protective effect against Mycobacterium leprae transmission.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Post-exposure prophylaxis (PEP) with single-dose rifampicin is known to reduce the progression from Mycobacterium leprae infection to leprosy disease.
- This study investigated the effectiveness of different administration modalities of single double-dose rifampicin (SDDR)-PEP, including a higher dosage (20 mg/kg).
Purpose of the Study:
- To compare the effectiveness of various SDDR-PEP administration strategies in reducing leprosy incidence.
- To assess the individual protective effect of SDDR-PEP and explore spatial associations with leprosy transmission.
Main Methods:
- A cluster randomized study was conducted in Madagascar and Comoros over 4 years, involving annual leprosy screening.
- Four study arms were implemented: a control arm with no PEP, and three intervention arms with varying SDDR-PEP distribution (household contacts, proximity within 100m, or proximity with positive serology).
- Participants aged 2 years and older were eligible, with leprosy patients receiving multidrug therapy and asymptomatic contacts receiving SDDR-PEP.
Main Results:
- Overall, SDDR-PEP showed a non-significant reduction in leprosy incidence across intervention arms.
- However, after adjusting for baseline prevalence, arm 3 (SDDR-PEP within 100m) demonstrated a significant reduction (IRR 0.56, p=0.0030).
- Individually, SDDR-PEP was protective (IRR 0.55, p=0.0050), with leprosy risk increasing significantly for individuals living within 75m of an index patient.
Conclusions:
- SDDR-PEP demonstrates protective effects against leprosy, though potentially less than initially anticipated.
- Strong spatial clustering of leprosy cases was observed, highlighting the importance of proximity to infected individuals.
- A combined strategy of targeted door-to-door screening around index patients and widespread SDDR-PEP administration is likely to significantly reduce leprosy transmission.
More Related Videos
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
10:47Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
Published on: July 1, 2011
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...